WHI
IONS icon

William Harris Investors’s Ionis Pharmaceuticals IONS Stock Holding History

William Harris Investors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.82M Sell
79,800
-240,218
-75% -$9.51M 1.1% 36
2016
Q3 		$11.7M Sell
320,018
-60,000
-16% -$1.88M 3.17% 8
2016
Q2 		$8.85M Buy
380,018
+55,556
+17% +$1.79M 2.22% 15
2016
Q1 		$13.1M Buy
324,462
+94,019
+41% +$3.82M 3.29% 9
2015
Q4 		$14.3M Sell
230,443
-86,858
-27% -$4.69M 3.43% 8
2015
Q3 		$12.8M Buy
317,301
+88,147
+38% +$4.56M 3.63% 6
2015
Q2 		$13.2M Sell
229,154
-733
-0.3% -$46.6K 3.67% 7
2015
Q1 		$14.6M Sell
229,887
-46,983
-17% -$3.19M 3.84% 6
2014
Q4 		$17.1M Sell
276,870
-33,064
-11% -$1.63M 4.41% 3
2014
Q3 		$12M Sell
309,934
-19,100
-6% -$677K 3.6% 9
2014
Q2 		$11.3M Buy
329,034
+122,100
+59% +$3.84M 3.14% 10
2014
Q1 		$8.94M Sell
206,934
-76,900
-27% -$3.73M 2.58% 15
2013
Q4 		$11.3M Sell
283,834
-29,000
-9% -$1.03M 3.35% 10
2013
Q3 		$11.7M Sell
312,834
-13,000
-4% -$388K 3.67% 8
2013
Q2 		$8.76M Buy
+325,834
New +$6.93M 2.66% 15

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Harris Investors's IONS Position: Q4 2016 in Review

William Harris Investors reduced its Ionis Pharmaceuticals (IONS) stake by 75% in Q4 2016, selling an estimated $9.51M and leaving 79,800 shares worth $3.82M. The position accounts for 1.1% of the portfolio, ranked #36.

William Harris Investors first reported a position in IONS in Q2 2013 and has held it in 15 quarters since. The position peaked at $17.1M in Q4 2014. 309 funds tracked by Wall St. Rank hold IONS as of Q4 2016.

  • William Harris Investors held 79,800 shares of Ionis Pharmaceuticals worth $3.82M as of Q4 2016.
  • William Harris Investors sold 240,218 Ionis Pharmaceuticals shares in Q4 2016, an estimated $9.51M.
  • Ionis Pharmaceuticals made up 1.1% of William Harris Investors's portfolio in Q4 2016, its #36 holding.
  • William Harris Investors first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • William Harris Investors's Ionis Pharmaceuticals position peaked at $17.1M in Q4 2014.
  • 309 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2016.

Based on William Harris Investors's 13F filing for Q4 2016, filed 7 Feb 2017.